Anti-CRUM1/ CRB1/ LCA8 monoclonal antibody

Anti-CRUM1/ CRB1/ LCA8 antibody for FACS & in-vivo assay

Target products collectionGo to CRB1/CRB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0331-Ab-1/ GM-Tg-hg-MP0331-Ab-2Anti-Human CRB1 monoclonal antibodyHuman
GM-Tg-rg-MP0331-Ab-1/ GM-Tg-rg-MP0331-Ab-2Anti-Rat CRB1 monoclonal antibodyRat
GM-Tg-mg-MP0331-Ab-1/ GM-Tg-mg-MP0331-Ab-2Anti-Mouse CRB1 monoclonal antibodyMouse
GM-Tg-cynog-MP0331-Ab-1/ GM-Tg-cynog-MP0331-Ab-2Anti-Cynomolgus/ Rhesus macaque CRB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0331-Ab-1/ GM-Tg-felg-MP0331-Ab-2Anti-Feline CRB1 monoclonal antibodyFeline
GM-Tg-cang-MP0331-Ab-1/ GM-Tg-cang-MP0331-Ab-2Anti-Canine CRB1 monoclonal antibodyCanine
GM-Tg-bovg-MP0331-Ab-1/ GM-Tg-bovg-MP0331-Ab-2Anti-Bovine CRB1 monoclonal antibodyBovine
GM-Tg-equg-MP0331-Ab-1/ GM-Tg-equg-MP0331-Ab-2Anti-Equine CRB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0331-Ab-1/ GM-Tg-hg-MP0331-Ab-2; GM-Tg-rg-MP0331-Ab-1/ GM-Tg-rg-MP0331-Ab-2;
GM-Tg-mg-MP0331-Ab-1/ GM-Tg-mg-MP0331-Ab-2; GM-Tg-cynog-MP0331-Ab-1/ GM-Tg-cynog-MP0331-Ab-2;
GM-Tg-felg-MP0331-Ab-1/ GM-Tg-felg-MP0331-Ab-2; GM-Tg-cang-MP0331-Ab-1/ GM-Tg-cang-MP0331-Ab-2;
GM-Tg-bovg-MP0331-Ab-1/ GM-Tg-bovg-MP0331-Ab-2; GM-Tg-equg-MP0331-Ab-1/ GM-Tg-equg-MP0331-Ab-2
Products NameAnti-CRB1 monoclonal antibody
Formatmab
Target NameCRB1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CRB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CRUM1/ CRB1/ LCA8 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0331
    Target NameCRB1
    Gene ID23418,170788,304825,710991,490260,101092328,520406,100061068
    Gene Symbol and Synonyms7530426H14Rik,A930008G09Rik,CRB1,CRB1-A,CRB1-A2,CRB1-B,CRB1-C,LCA8,RP12
    Uniprot AccessionP82279
    Uniprot Entry NameCRUM1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134376
    Target ClassificationN/A

    The target: CRB1, gene name: CRB1, also named as LCA8, RP12. This gene encodes a protein which is similar to the Drosophila crumbs protein and localizes to the inner segment of mammalian photoreceptors. In Drosophila crumbs localizes to the stalk of the fly photoreceptor and may be a component of the molecular scaffold that controls proper development of polarity in the eye. Mutations in this gene are associated with a severe form of retinitis pigmentosa, RP12, and with Leber congenital amaurosis. Alternate splicing results in multiple transcript variants, some protein coding and some non-protein coding.[provided by RefSeq, Apr 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.